Greeting from the new president


First of all, I would like to extend my deepest sympathy to all who have been facing hardship due to the global COVID-19 pandemic. I would also like to express my heartfelt respect and gratitude toward everyone who is working to treat the disease and halt its spread, including healthcare and medical workers.

Nippon Fine Chemical was established in 1918 as Nippon Camphor Co., Ltd., with the goal of consolidating the domestic camphor industry in Japan.

Later, we expanded its business domain as it began to manufacture fatty acids and other oil and fat products while developing unique operations in the chemical industry. Since we have changed our company name to Nippon Fine Chemical Co., Ltd., in 1971, we have been working on developing products and businesses that anticipate the needs of the times as a fine chemical manufacture.

Today, our operations span a broad range of fields, including people- and environment-friendly cosmetic ingredients; hygiene management products that help keep people’s living environment clean, safe, and comfortable; pharmaceutical ingredients designed to improve health and convenience; and industrial raw materials that are used not only in familiar daily necessities, but also in electronic materials and functional resins.

After celebrating the 100th anniversary of our founding on February 12, 2018, we began implementing a new medium-term management plan (covering FY2019 to FY2023) in April 2018. In keeping with our slogan of “sustainable growth for the next 100 years,” that plan is conceived to enable us to play an indispensable role in society by providing value that supports people's beauty and health and the realization of an affluent life.

During this fiscal year, which marks the midpoint of the plan, we will accelerate implementation of our growth strategy, for example by investing some ¥2.7 billion in our Takasago Plant in Hyogo Prefecture and starting construction of a new plant that is scheduled to start operating in 2022. The overarching goal of these steps is to accommodate expected future growth in demand for pharmaceutical-use phospholipids that are utilized in drug delivery systems (DDSs), which have been attracting attention in recent years as an essential technology for maximizing the effectiveness of pharmaceuticals while reducing their side effects.

The COVID-19 pandemic is having impacts in daily life and across the real economy; we, too, find ourselves operating in an extremely challenging environment. These challenges provide an ideal opportunity to reflect on our corporate philosophy of “contributing to society through all of its businesses” as we pool our strengths to embrace ever more ambitious goals and achieve them through sustained innovation.

We would like to thank all of our stakeholders for your continued support.

Management Philosophy

  • Nippon Fine Chemical shall contribute to society through all of its businesses
  • Nippon Fine Chemical shall contribute to all people associated with it
  • Nippon Fine Chemical shall contribute to self-realization of its employees

Representative Director, President
Hiroshi Yano